| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | MODIFI BIOSCIENCES INC | 55 CHURCH ST STE 200 | NEW HAVEN | CT | 06510-3029 | SOUTH CENTRAL CT | USA | R44CA271994 | Development of Targeted Damaging Agents for the Treatment of Drug-Resistant Gliomas | 000 | 3 | NIH | 4/1/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $892,099 ) |
| | 2024 | 2024 | MODIFI BIOSCIENCES INC | 55 CHURCH ST STE 200 | NEW HAVEN | CT | 06510-3029 | SOUTH CENTRAL CT | USA | R44CA271994 | Development of Targeted Damaging Agents for the Treatment of Drug-Resistant Gliomas | 002 | 3 | NIH | 12/27/2023 | $892,099 |
| | 2024 | 2023 | MODIFI BIOSCIENCES INC | 55 CHURCH ST STE 200 | NEW HAVEN | CT | 06510-3029 | SOUTH CENTRAL CT | USA | R44CA271994 | Development of Targeted Damaging Agents for the Treatment of Drug-Resistant Gliomas | 001 | 2 | NIH | 12/27/2023 | $0 |
| | 2024 | 2022 | MODIFI BIOSCIENCES INC | 55 CHURCH ST STE 200 | NEW HAVEN | CT | 06510-3029 | SOUTH CENTRAL CT | USA | R44CA271994 | Development of Targeted Damaging Agents for the Treatment of Drug-Resistant Gliomas | 000 | 1 | NIH | 12/1/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,107,901 ) |
| | 2023 | 2023 | AZTEK BIO, INC. | 55 CHURCH STREET, SUITE 200 | NEW HAVEN | CT | 06510-3029 | SOUTH CENTRAL CT | USA | R44CA271994 | Development of Targeted Damaging Agents for the Treatment of Drug-Resistant Gliomas | 001 | 2 | NIH | 4/20/2023 | $1,107,901 |
| | 2023 | 2022 | AZTEK BIO, INC. | 55 CHURCH STREET, SUITE 200 | NEW HAVEN | CT | 06510-3029 | SOUTH CENTRAL CT | USA | R44CA271994 | Development of Targeted Damaging Agents for the Treatment of Drug-Resistant Gliomas | 000 | 1 | NIH | 4/19/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $400,000 ) |
| | 2022 | 2022 | AZTEK BIO, INC. | 36 CHURCH LN | WESTPORT | CT | 06880-3505 | WESTERN CT | USA | R44CA271994 | Development of Targeted Damaging Agents for the Treatment of Drug-Resistant Gliomas | 000 | 1 | NIH | 8/29/2022 | $400,000 |
|
|
